Cargando…
Drotrecogin alpha: a rational approach to the treatment of submassive pulmonary embolism?
Combining therapeutic doses of low-molecular-weight heparins and increasing doses of recombinant activated protein C - Drotrecogin alpha (activated), or DAA - is of theoretical interest with regard to the control of coagulation activation. The study by Dempfle and colleagues presents new data showin...
Autores principales: | Samama, Charles Marc, Godier, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3221987/ https://www.ncbi.nlm.nih.gov/pubmed/21345242 http://dx.doi.org/10.1186/cc10027 |
Ejemplares similares
-
Thrombolytic therapy in submassive pulmonary embolism
por: Özlek, Eda, et al.
Publicado: (2017) -
Submassive Pulmonary Embolism and Left Atrial Thrombus
por: Konik, Ewa, et al.
Publicado: (2018) -
Low-dose thrombolysis for submassive pulmonary embolism
por: Yilmaz, Emine Serap, et al.
Publicado: (2021) -
Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism
por: FEI, JIANWEN, et al.
Publicado: (2014) -
Submassive Pulmonary Embolism Complicating Small Bowel Obstruction
por: Sagalov, Andrew, et al.
Publicado: (2021)